|
|
Office Locations:
|
|
|
|
|
Information Technology
Life Sciences & Healthcare
Software & Internet
|
|
|
|
Byers Capital is an investment vehicle for Blake Byers, a partner at Google Ventures for a decade. Recent investments include Culdesac, Vial, Benchling, Neuralink, and Freenome. Byers leads and participates in financings, most often for a company's Series A + B rounds. He cofounded NewLimit with Brian Armstrong to extend human health span by inventing epigenetic reprogramming medicines.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
